Pradžia › Geltonosios dėmės degeneracija › Nevada
Geltonosios dėmės degeneracija klinikiniai tyrimai Nevada
8 tyrimai dėl Geltonosios dėmės degeneracija ieško dalyvių vietose Nevada.
Miestai Nevada
Oficialus tyrimo tekstas (anglų kalba)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Sierra Eye Associates, Reno
Renkami dalyviai2/3 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT06635148A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Sierra Eye Associates, Reno
Renkami dalyviai1/2 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT07029945Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Sierra Eye Associates, Reno
Renkami dalyviai2 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT06659445A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
- Sierra Eye Associates, Reno
Renkami dalyviaiStebimasis tyrimas
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT07144137Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
- Sierra Eye Associates, Reno
Renkami dalyviai
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-08-26 · NCT066621624D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- Sierra Eye Associates, Reno
Renkami dalyviai1/2 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-08-21 · NCT05197270Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Sierra Eye Associates /ID# 262142, Reno
Renkami dalyviai1/2 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-07-13 · NCT07160179Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Sierra Eye Associates, Reno
Renkami dalyviai3 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-04-16 · NCT07064759Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.